PREVNAR 13® Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Adult

Indications for Prevnar 13^®

Prevnar 13^® is a vaccine approved for adults 50 years of age and older for the prevention of pneumococcal pneumonia and invasive disease caused by 13 Streptococcus pneumoniae strains (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). This indication is based upon immune responses to the vaccine

For children 6 weeks through 17 years of age, Prevnar 13^® is approved for the prevention of invasive disease caused by the 13 vaccine strains, and for children 6 weeks through 5 years for the prevention of otitis media caused by 7 of the 13 strains

Prevnar 13^® is not 100% effective and will only help protect against the 13 strains included in the vaccine

Effectiveness when given less than 5 years after a pneumococcal polysaccharide vaccine is not known

Important Safety Information

Prevnar 13^® should not be given to anyone with a history of severe allergic reaction to any component of Prevnar 13^® or any diphtheria toxoid–containing vaccine

Children and adults with weakened immune systems (eg, HIV infection, leukemia) may have a reduced immune response

In adults, immune responses to Prevnar 13^® were reduced when given with injected seasonal flu vaccine

In adults, the common side effects were pain, redness, or swelling at the injection site, limitation of arm movement, fatigue, headache, muscle pain, joint pain, decreased appetite, chills, or rash

A temporary pause of breathing following vaccination has been observed in some infants born prematurely

The most commonly reported serious adverse events in infants and toddlers were bronchiolitis (an infection of the lungs) (0.9%), gastroenteritis (inflammation of the stomach and small intestine) (0.9%), and pneumonia (0.9%)

In children 6 weeks through 17 years, the most common side effects were tenderness, redness, or swelling at the injection site, irritability, decreased appetite, decreased or increased sleep, and fever. Most commonly reported side effects in children 5 years through 17 years also included hives

Ask your health care provider about the risks and benefits of Prevnar 13^®. Only a health care provider can decide if Prevnar 13^® is right for you

Text size: A A A

Pneumococcal pneumonia can be serious. It may be preventable.

Pneumococcal pneumonia can be serious. It's a bacterial illness that can be contagious and is responsible for as many as 302,000 hospitalizations in the United States each year. Pneumococcal pneumonia isn't like the common cold. Its symptoms can be severe and last for weeks—or months.

Many people dismiss pneumonia as an illness that elderly or sick people get in the hospital. It's not. The reality is that most cases of pneumonia in the United States are acquired while people are going about their daily lives. And even people as young as 50 are at increased risk.

If you're 50 or older, vaccination is an option that may help you prevent getting pneumococcal pneumonia in the first place.

Understand pneumococcal pneumonia in 90 seconds.

From causes to impact to prevention options, learn more about this serious—and often misunderstood—disease.

Prevnar 13^® is a vaccine for use in adults 50 and over.

Delivered by injection in a single dose in adults 50 years of age and older, Prevnar 13^® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM₁₉₇ Protein]) is a vaccine indicated for active immunization for the prevention of pneumonia and invasive disease caused by 13 strains of Streptococcus pneumoniae (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F). This indication is based on immune responses elicited by Prevnar 13^®. There have been no controlled trials in adults demonstrating a decrease in pneumococcal pneumonia or invasive disease after vaccination with Prevnar 13^®. Prevnar 13^® will not protect against disease caused by strains of Streptococcus pneumoniae not contained in the vaccine.

Learn about Prevnar 13^®

Indications for Prevnar 13®

Important Safety Information

Pneumococcal pneumonia can be serious. It may be preventable.

Understand pneumococcal pneumonia in 90 seconds.

Prevnar 13® is a vaccine for use in adults 50 and over.

Indications for Prevnar 13^®

Prevnar 13^® is a vaccine for use in adults 50 and over.